Lv1
50 积分 2024-08-07 加入
Targeted therapies for cutaneous T-cell lymphomas
1个月前
已关闭
Targeted therapies for cutaneous T-cell lymphomas
1个月前
已关闭
Therapeutic advances for Cutaneous T Cell Lymphoma
1个月前
已完结
Circulating Tumor DNA as Measurable Residual Disease in Aggressive B-Cell Lymphoma
1个月前
已完结
Linperlisib Plus Chidamide in Relapsed or Refractory Cutaneous T-Cell Lymphoma
2个月前
已完结
Nivolumab-AVD Versus Brentuximab Vedotin–AVD in Older Patients With Advanced-Stage Classic Hodgkin Lymphoma Enrolled on S1826
2个月前
已关闭
Final analysis of the RESONATE-2 study: up to 10 years of follow-up of first-line ibrutinib treatment for CLL/SLL
3个月前
已关闭
Enhanced CAR T-Cell Therapy for Lymphoma after Previous Failure
6个月前
已完结
Treatment of Relapsed/Refractory MCL
6个月前
已完结
皖公网安备34019202002308
